These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26882287)

  • 1. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
    Foo WC; Jo VY; Krane JF
    Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
    Avadhani V; Cohen C; Siddiqui MT
    Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens.
    Pusztaszeri MP; Sadow PM; Ushiku A; Bordignon P; McKee TA; Faquin WC
    Cancer Cytopathol; 2014 Apr; 122(4):257-65. PubMed ID: 24302647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYB expression: Potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA).
    Moon A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Oct; 44(10):799-804. PubMed ID: 27491495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Andreasen S; von Holstein SL; Homøe P; Heegaard S
    Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
    Rotellini M; Palomba A; Baroni G; Franchi A
    Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric epithelial salivary gland tumors: spectrum of histologies and cytogenetics at a children's hospital.
    Craver RD; Fonseca P; Carr R
    Pediatr Dev Pathol; 2010; 13(5):348-53. PubMed ID: 20055685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual pleomorphic adenoma of the lacrimal Gland: Immunohistochemical demonstration of PLAG1 and HMGA2 oncoproteins.
    Jakobiec FA; Stagner AM; Eagle RC; Lally SE; Krane JF
    Surv Ophthalmol; 2017; 62(2):219-226. PubMed ID: 27567603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
    Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
    Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
    Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization.
    Hudson JB; Collins BT
    Arch Pathol Lab Med; 2014 Mar; 138(3):403-9. PubMed ID: 24576033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
    Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BOC-PLAG1, a new fusion gene of pleomorphic adenoma: Identified in a fine-needle aspirate by RNA next-generation sequencing.
    Pei J; Liu JC; Ehya H; Wei S
    Diagn Cytopathol; 2021 Jun; 49(6):790-792. PubMed ID: 33710800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial fibrillary acidic protein and CD57 immunolocalization in cell block preparations is a useful adjunct in the diagnosis of pleomorphic adenoma.
    Shah SS; Chandan VS; Wilbur DC; Khurana KK
    Arch Pathol Lab Med; 2007 Sep; 131(9):1373-7. PubMed ID: 17824792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.
    Matsuyama A; Hisaoka M; Hashimoto H
    Pathol Int; 2012 Jan; 62(1):1-7. PubMed ID: 22192798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical features of lacrimal gland epithelial tumors.
    Mendoza PR; Jakobiec FA; Krane JF
    Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
    Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
    El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
    Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.